004: Finding Funding In Volatile Times With Dr. Ben Zeskind

We love to hear from our listeners. Send us a message. This week's Business Of Biotech pod features Immuneering CEO Dr. Ben Zeskind, who launched his biotech on the back of creative financing in the throes of the Great Recession. A pivot into biopharma landed Immuneering a $20 million series A round to develop its pipeline--at the outset of the COVID-19 pandemic. Dr. Zeskind joins us for a candid and instructive discussion on getting creative when the economy isn't exactly booming. Acces...